CRUK Cambridge Centre

  • Functional Genomics Centre launched to accelerate drug discovery
  • Dr Suzanne Turner comments on cancer linked to breast implants
  • Pancreatic cancer pioneers awarded £200K for 'barcode' cancer tech
  • Professor Rebecca Fitzgerald awarded Jane Wardle Prize 2018
  • Study shows potential to develop brain tumour liquid biopsies
  • Dr Charlotte Coles, Researcher of the Year, Cambridge Independent

The CRUK Cambridge Centre is a dynamic collaboration of researchers, clinicians, and the pharmaceutical and biotech industries based in the Cambridge area. We combine world-class science and technology with excellent patient care to pioneer new ways to prevent, detect and treat cancer.

By working together across different disciplines, we are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

Patient care and clinical research
We offer a leading cancer care specialist service at Addenbrooke’s Hospital. We are committed to translating our clinical research to improve patient outcomes by recruiting the highest proportion of patients onto clinical trials in the UK.
Over 140 research groups work together across traditional academic, commercial and clinical boundaries. We connect cutting-edge science and technology from different disciplines to shed new light on preventing and controlling cancer.
Education and training
We educate and train the next generation of cancer scientists and clinicians. Working with the University of Cambridge we provide a stimulating learning environment for undergraduates, graduates, and postdoctoral researchers.

Subscribe to Centre News Latest news and events from CRUK Cambridge Centre

New centre will use CRISPR technology, big data and clinical insights to discover new drugs for cancer patients.
Dr Suzanne Turner comments on concerns around Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
A new system developed by Cambridge computer scientists and cancer researchers may accelerate search for cancer-related discoveries.